News articles about McKesson Corporation (NYSE:MCK) have been trending somewhat positive on Tuesday, according to Accern Sentiment Analysis. The research firm rates the sentiment of news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. McKesson Corporation earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 44.801441624888 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
Here are some of the news stories that may have impacted Accern Sentiment’s analysis:
- McKesson Signs Agreement With NRG to Install Solar Arrays at … – Business Wire (press release) (businesswire.com)
- Amid opioid crisis, Texas subsidized drug company it’s now investigating – Texas Tribune (texastribune.org)
- Jefferies Group Comments on McKesson Corporation’s FY2018 Earnings (MCK) (americanbankingnews.com)
- Research Analysts Issue Forecasts for McKesson Corporation’s FY2018 Earnings (MCK) (americanbankingnews.com)
- McKesson Corporation (MCK) Rating Reiterated by Royal Bank Of Canada (americanbankingnews.com)
Several analysts recently issued reports on the company. Royal Bank Of Canada assumed coverage on McKesson Corporation in a report on Tuesday, September 19th. They issued a “sector perform” rating and a $168.00 price target for the company. Jefferies Group LLC set a $165.00 price target on McKesson Corporation and gave the company a “hold” rating in a report on Wednesday, October 18th. Cowen and Company upgraded McKesson Corporation from a “market perform” rating to an “outperform” rating and increased their price target for the company from $176.00 to $189.00 in a report on Tuesday, October 10th. Needham & Company LLC set a $179.00 price target on McKesson Corporation and gave the company a “buy” rating in a report on Monday, October 16th. Finally, BidaskClub downgraded McKesson Corporation from a “sell” rating to a “strong sell” rating in a report on Saturday, August 19th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and eleven have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $174.62.
McKesson Corporation (NYSE MCK) opened at 135.02 on Tuesday. McKesson Corporation has a 12 month low of $126.30 and a 12 month high of $169.29. The stock’s 50 day moving average is $150.50 and its 200 day moving average is $153.61. The company has a market cap of $28.39 billion, a PE ratio of 6.13 and a beta of 1.17.
McKesson Corporation (NYSE:MCK) last posted its quarterly earnings data on Thursday, October 26th. The company reported $3.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.78 by $0.50. McKesson Corporation had a net margin of 2.24% and a return on equity of 24.87%. The company had revenue of $52.06 billion for the quarter, compared to the consensus estimate of $51.69 billion. During the same quarter in the previous year, the firm posted $2.94 EPS. The business’s revenue was up 4.2% compared to the same quarter last year. Equities analysts predict that McKesson Corporation will post $12.07 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 2nd. Stockholders of record on Friday, December 1st will be issued a dividend of $0.34 per share. The ex-dividend date is Thursday, November 30th. This represents a $1.36 annualized dividend and a dividend yield of 1.01%. McKesson Corporation’s payout ratio is 6.45%.
In other news, SVP Erin M. Lampert sold 900 shares of the business’s stock in a transaction dated Thursday, September 7th. The shares were sold at an average price of $155.65, for a total transaction of $140,085.00. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO John H. Hammergren sold 100,000 shares of the business’s stock in a transaction dated Tuesday, September 26th. The stock was sold at an average price of $154.81, for a total transaction of $15,481,000.00. Following the transaction, the chief executive officer now owns 165,000 shares in the company, valued at approximately $25,543,650. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 950,983 shares of company stock worth $145,560,946. Insiders own 1.20% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This report was originally published by Community Financial News and is the sole property of of Community Financial News. If you are reading this report on another domain, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this report can be viewed at https://www.com-unik.info/2017/10/31/mckesson-corporation-mck-earns-news-impact-rating-of-0-15.html.
About McKesson Corporation
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally.
What are top analysts saying about McKesson Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for McKesson Corporation and related companies.